![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Roche to Pay Evotec $10 Million for Right to Experimental Alzheimer’s Drug
Roche to Pay Evotec $10 Million for Right to Experimental Alzheimer’s Drug
September 6, 2011
Roche Holding will pay Evotec $10 million for the right to develop Evotec’s EVT 302 compound for Alzheimer’s disease.
Bloomberg
Bloomberg
Upcoming Events
-
21Oct